Clinical Trials
33 trialsExploration of DNA Methylation as a Marker for Early Detection of High Grade Serous Epithelial Ovarian Cancer
Baylor Research Institute
ZERO2
Australian & New Zealand Children's Haematology/Oncology Group
Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia
Alliance for Clinical Trials in Oncology
I-share
University of Aarhus
DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia
Eastern Cooperative Oncology Group
Epigenetic Changes in Hepatocellular Carcinoma Developed After Direct Acting Antiviral Therapy for Chronic Hepatitis C
Assiut University
DNA in Predicting Response After Systemic Therapy in Women With Metastatic Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
DNA Methylation for Screening Uterine Cervical Lesions
Peking Union Medical College Hospital
DNA Methylation for Screening Uterine Cervical Lesions: A Case-control Study
Peking Union Medical College Hospital
Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Studying DNA and Outcome in Patients With Advanced Colorectal Cancer Treated With Fluorouracil and Oxaliplatin With or Without Bevacizumab on Clinial Trial E-3200
Eastern Cooperative Oncology Group
Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate
Eastern Cooperative Oncology Group
Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia
Eastern Cooperative Oncology Group
Biomarkers in Tissue and Blood Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor
Children's Oncology Group
Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia
Children's Oncology Group
Biomarkers in Patients With Rhabdomyosarcoma
Children's Oncology Group
Biomarker Changes in Samples From Young Patients With Acute Myeloid Leukemia
Children's Oncology Group
Biomarkers in Young Patients With Neuroblastoma
Children's Oncology Group
Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression
Children's Oncology Group
Studying Genes in Samples From Younger Patients With Adrenocortical Tumor
Children's Oncology Group
Studying Genes Using Cord Blood and Placenta Samples From Relatively Healthy Newborns and Samples From Younger Patients With Wilms Tumor
Children's Oncology Group
DNA Tests in Detecting Disseminated Disease in Tumor, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma
Children's Oncology Group
S8600-S9031-S9333-A, Study of DNA in Samples From Patients With Acute Myeloid Leukemia
SWOG Cancer Research Network
Fludeoxyglucose F 18 PET Imaging in Determining Protein and Gene Expression Signatures in Patients With Premalignant Polyps or Colon Cancer
Memorial Sloan Kettering Cancer Center
Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, Stage II, Stage III Breast Cancer, or Ductal Carcinoma In Situ That Can Be Removed By Surgery
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Biomarkers in Tumor Tissue Samples From Young Patients With Very Low Risk Wilms Tumors
Children's Oncology Group
S9031-S9126-S9333-S9500-A, Studying Bone Marrow and Blood Samples From Patients With Acute Myeloid Leukemia
SWOG Cancer Research Network
PRESEPT
Epigenomics, Inc
Biomarkers in Samples From Adult Patients With Acute Myeloid Leukemia Who Failed Existing Standard-of-Care Treatment
National Cancer Institute (NCI)
Liverpool Lung Project: Risk Factors and Genetic Markers in Healthy Participants and Patients With Lung Cancer
National Cancer Institute (NCI)
Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer
Cancer Research UK, Glasgow
Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants
National Cancer Institute (NCI)